Datroway

Blue race track
Favicon Fierce Pharma

Merck grows more ambitious about 'workhorse' TROP2 ADC

Merck has already registered 15 global phase 3 trials for its Kelun-partnered TROP2 antibody-drug conjugate, sac-TMT.
Angus Liu Oct 20, 2025 4:00pm
Roche

Roche nets FDA breakthrough label for AI lung cancer CDx test

Apr 29, 2025 2:07pm